AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21256048 — intervention group
Group type: COMPARATOR
Intervention: PBO add-on to bosentan
Number of subjects: 405
Study 21256048 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil monotherapy and as add-on
Number of subjects: 405
Study 19120729 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction of oral secretion before each positional care
Number of subjects: 261
Study 19120729 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 261
Study 17534812 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% unpreserved lidocaine (Group 2)
Number of subjects: 96
Study 17534812 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (Group 1)
Number of subjects: 96
Study 17534812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sedation
Number of subjects: 96
Study 15155352 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (66% nitrous oxide used in group N)
Number of subjects: 24
Study 15155352 — intervention group
Group type: COMPARATOR
Intervention: Air (no nitrous oxide used in group A)
Number of subjects: 24
Study 15155352 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative airway complications
Number of subjects: 24
Study 11822847 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of clinical practice guidelines for the management of venous leg ulcers
Number of subjects: 0
Study 11822847 — intervention group
Group type: EXPERIMENTAL
Intervention: Preliminary needs analysis of contextual hurdles and levers
Number of subjects: 0
Study 9503547 — intervention group
Group type: EXPERIMENTAL
Intervention: FK 506
Number of subjects: 41
Study 9503547 — intervention group
Group type: COMPARATOR
Intervention: CyA
Number of subjects: 41
Study 9175947 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 40
Study 9175947 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone
Number of subjects: 40
Study 9175947 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study 2126475 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural porcine surfactant treatment
Number of subjects: 33
Study 2126475 — intervention group
Group type: COMPARATOR
Intervention: Control (no surfactant treatment)
Number of subjects: 33
Study 6454596 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 11-1430
Number of subjects: 60
Study 6454596 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin
Number of subjects: 60
Study 31914930 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 122
Study 31914930 — intervention group
Group type: COMPARATOR
Intervention: Control (Normal saline)
Number of subjects: 122
Study 31671514 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise program (Korean dance and yoga), 60 min/day, 3 times/week for 12 weeks
Number of subjects: 25
Study 31671514 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 25
Study 27980249 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rest (short-time exercise) program consisting of warm-up, cognitive functional training, aerobic exercise, resistance training, and cool-down for 10 minutes per day, 3 times per week for 10 weeks
Number of subjects: 59
Study 27980249 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rest (short-time exercise) program
Number of subjects: 59
Study 25242059 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Stoplight Diet (SLDm) supplemented with portion-controlled meals
Number of subjects: 126
Study 25242059 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) - modified version of the MyPlate diet
Number of subjects: 126
Study 25242059 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Stoplight Diet (SLDm)
Number of subjects: 126
Study 23886232 — intervention group
Group type: EXPERIMENTAL
Intervention: Auvi-Q
Number of subjects: 71
Study 23886232 — intervention group
Group type: COMPARATOR
Intervention: EpiPen
Number of subjects: 71
Study 20167430 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal methylene blue injection
Number of subjects: 72
Study 20167430 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 72
Study 18254487 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib, 40 mg
Number of subjects: 79
Study 18254487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 16494640 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of ramipril 2.5 mg/felodipine ER 2.5 mg
Number of subjects: 149
Study 16494640 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 2.5 mg
Number of subjects: 149
Study 16494640 — intervention group
Group type: COMPARATOR
Intervention: Felodipine ER 2.5 mg
Number of subjects: 149
Study 14627848 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET
Number of subjects: 16
Study 14627848 — intervention group
Group type: COMPARATOR
Intervention: [99mTc]pertechnetate scintigraphy
Number of subjects: 16
Study 10764312 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroid treatment arm
Number of subjects: 261
Study 10764312 — intervention group
Group type: EXPERIMENTAL
Intervention: FEV(1) at entry into the study
Number of subjects: 261
Study 10764312 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in FEV(1) over the first two Study Days
Number of subjects: 261
Study 10764312 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment failure (defined as death, intubation, readmission for COPD, or intensification of drug therapy)
Number of subjects: 261
Study 8916534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dust levels
Number of subjects: 0
Study 8916534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentrations of nitrogen dioxide
Number of subjects: 0
Study 8916534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher TVOCs
Number of subjects: 0
Study 8916534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher nitrogen dioxide
Number of subjects: 0
Study 8916534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher total contaminant load
Number of subjects: 0
Study 1756437 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin, 150 mg daily for 3 days
Number of subjects: 9
Study 7059922 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling by a counselor
Number of subjects: 120
Study 7059922 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 120
Study 30581128 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the right DLPFC
Number of subjects: 54
Study 30581128 — intervention group
Group type: COMPARATOR
Intervention: Anodal tDCS to the left DLPFC
Number of subjects: 54
Study 30581128 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 54
Study 27385542 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 22
Study 27385542 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 22
Study 27385542 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+
Number of subjects: 22
Study 27283479 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (n=2543)
Number of subjects: 7447
Study 27283479 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts (n=2454)
Number of subjects: 7447
Study 27283479 — intervention group
Group type: COMPARATOR
Intervention: Control diet (advice to reduce dietary fat; n=2450)
Number of subjects: 7447
Study 24410411 — intervention group
Group type: EXPERIMENTAL
Intervention: Active exercise
Number of subjects: 89
Study 24410411 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD)
Number of subjects: 89
Study 22995880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraprocedural complications (n=166, 11.4%)
Number of subjects: 1452
Study 22995880 — intervention group
Group type: COMPARATOR
Intervention: No intraprocedural complications
Number of subjects: 1452
Study 19545851 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft contact lenses
Number of subjects: 20
Study 19545851 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid gas-permeable (GP) contact lenses
Number of subjects: 20
Study 17634903 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron intravenously for 5 days
Number of subjects: 108
Study 17634903 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 108
Study 17634903 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 108
Study 15347114 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundus-first laparoscopic cholecystectomy
Number of subjects: 145
Study 15347114 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 145
Study 11590553 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT) with estradiol 2 mg/day for 10 weeks
Number of subjects: 30
Study 11590553 — intervention group
Group type: COMPARATOR
Intervention: Control group of 12 healthy postmenopausal women (no ERT)
Number of subjects: 30
Study 11590553 — intervention group
Group type: COMPARATOR
Intervention: Control group of 11 comparably healthy age-matched men
Number of subjects: 30
Study 9586605 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixed-rate signal generator (cardiac simulator)
Number of subjects: 933
Study 9586605 — intervention group
Group type: COMPARATOR
Intervention: Electrocardiogram-gated SWL (no simulator)
Number of subjects: 933
Study 9586605 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 933
Study 9586605 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia
Number of subjects: 933
Study 9586605 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 933
Study 8006520 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoleic acid
Number of subjects: 34
Study 8006520 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitic acid
Number of subjects: 34
Study 8006520 — intervention group
Group type: COMPARATOR
Intervention: Oleic acid
Number of subjects: 34
Study 2461406 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 14
Study 2461406 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine
Number of subjects: 14
Study 2461406 — intervention group
Group type: COMPARATOR
Intervention: control day
Number of subjects: 14
Study 31899552 — intervention group
Group type: EXPERIMENTAL
Intervention: BMT‐CARE intervention
Number of subjects: 100
Study 31899552 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Comments on Google
Number of subjects: 849
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Comments on Medicosearch
Number of subjects: 849
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Comments on DocApp
Number of subjects: 849
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Comments on OkDoc
Number of subjects: 849
Study 31573918 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comments
Number of subjects: 849
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Negative comments on Google
Number of subjects: 849
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Negative comments regarding physicians in Zurich
Number of subjects: 849
Study 31573918 — intervention group
Group type: COMPARATOR
Intervention: Negative comments from specialists
Number of subjects: 849
Study 31573918 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal issues
Number of subjects: 849
Study 28329243 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent participants
Number of subjects: 0
Study 28329243 — intervention group
Group type: COMPARATOR
Intervention: Non-adherent participants
Number of subjects: 0
Study 25111547 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-enhancing writing (downward social comparison) among European Americans
Number of subjects: 34
Study 25111547 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-improving writing (persistence) among European Americans
Number of subjects: 34
Study 25111547 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-improving writing (persistence) among Asian Americans
Number of subjects: 34
Study 25111547 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-enhancing writing (downward social comparison) among Asian Americans
Number of subjects: 34
Study 25111547 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-improving writing (situational attributions) among Asian Americans
Number of subjects: 34
Study 23000088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ra 223 at 25 kBq/kg
Number of subjects: 122
Study 23000088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ra 223 at 50 kBq/kg
Number of subjects: 122
Study 23000088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ra 223 at 80 kBq/kg
Number of subjects: 122
Study 20821047 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole for 12 weeks followed by Anastrozole for 12 weeks
Number of subjects: 181
Study 20821047 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole for 12 weeks followed by Letrozole for 12 weeks
Number of subjects: 181
Study 20821047 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 181
Study 20821047 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 181
Study 20821047 — intervention group
Group type: COMPARATOR
Intervention: Both agents
Number of subjects: 181
Study 18204797 — intervention group
Group type: EXPERIMENTAL
Intervention: Knack maneuver
Number of subjects: 93
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 114
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 114
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate + Carbamazepine (combined therapy)
Number of subjects: 114
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 114
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term treatment (>10 years) with Valproate, Carbamazepine, and combined therapy
Number of subjects: 114
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum concentration of Valproate
Number of subjects: 114
Study 17199783 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum concentration of Carbamazepine
Number of subjects: 114
Study 12644958 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (1 mg/h, continuous IV infusion for 5 hours)
Number of subjects: 40
Study 12644958 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution, equal volume for 5 hours)
Number of subjects: 40
Study 12644958 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil and Placebo
Number of subjects: 40
Study 11054226 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended saphenofemoral junction (SFJ) ligation
Number of subjects: 180
Study 11054226 — intervention group
Group type: COMPARATOR
Intervention: No high ligation
Number of subjects: 180
Study 9052355 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute alcohol ingestion (ethanol blood concentration 1.3 +/- 0.4%)
Number of subjects: 20
Study 9052355 — intervention group
Group type: COMPARATOR
Intervention: Juice control
Number of subjects: 20
Study 8422814 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg b.i.d.)
Number of subjects: 442
Study 8422814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 442
Study 8422814 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil and Placebo
Number of subjects: 442
Study 8422814 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 442
Study 3510043 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium suspension with optimal viscosity (suspended with 65-70 ml water)
Number of subjects: 600
Study 3510043 — intervention group
Group type: COMPARATOR
Intervention: Barium suspension with high viscosity (same batch number, suspended with different water amounts)
Number of subjects: 600
Study 30040707 — intervention group
Group type: EXPERIMENTAL
Intervention: IASTM technique
Number of subjects: 45
Study 27163500 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 200 mg subcutaneously via autoinjector
Number of subjects: 81
Study 27163500 — intervention group
Group type: COMPARATOR
Intervention: Belimumab 200 mg subcutaneously via prefilled syringe
Number of subjects: 81
Study 24829212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 2413
Study 24829212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2413
Study 23028241 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine, 10 mL (Group I)
Number of subjects: 140
Study 23028241 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mL of 0.5% lidocaine mixed with 1 mL of 6 mg of nonparticulate betamethasone (Group II)
Number of subjects: 140
Study 19910499 — intervention group
Group type: EXPERIMENTAL
Intervention: Registered dietitian-led intervention group (n = 75)
Number of subjects: 154
Study 19910499 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care, n = 79)
Number of subjects: 154
Study 17651142 — intervention group
Group type: EXPERIMENTAL
Intervention: Aeroallergen sensitization assessment in 40-year-olds
Number of subjects: 7820
Study 16128861 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg acarbose
Number of subjects: 28
Study 16128861 — intervention group
Group type: COMPARATOR
Intervention: 100 g saccharose
Number of subjects: 28
Study 16128861 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 28
Study 12453138 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioengineered skin construct
Number of subjects: 143
Study 12453138 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 143
Study 12453138 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement Performance Index
Number of subjects: 143
Study 10450062 — intervention group
Group type: EXPERIMENTAL
Intervention: SangCya (test)
Number of subjects: 20
Study 10450062 — intervention group
Group type: COMPARATOR
Intervention: Neoral (reference)
Number of subjects: 20
Study 10450062 — intervention group
Group type: EXPERIMENTAL
Intervention: SangCya and Neoral
Number of subjects: 20
Study 8643419 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous Colles fracture group (n = 63)
Number of subjects: 63
Study 8643419 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 53)
Number of subjects: 63
Study 2145770 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms of desogestrel and 30 micrograms of ethinyl estradiol
Number of subjects: 60
Study 2145770 — intervention group
Group type: COMPARATOR
Intervention: 75 micrograms of gestodene and 30 micrograms of ethinyl estradiol
Number of subjects: 60
Study 1101231 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic psychologic preparation and continued supportive care
Number of subjects: 80
Study 1101231 — intervention group
Group type: COMPARATOR
Intervention: Control group (no systematic psychologic preparation and supportive care)
Number of subjects: 80
Study 31820593 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 0.1 mg/kg
Number of subjects: 94
Study 31820593 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 0.1 μg/kg
Number of subjects: 94
Study 31820593 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 94
Study 31437853 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge
Number of subjects: 80
Study 31437853 — intervention group
Group type: COMPARATOR
Intervention: Room air inhalation
Number of subjects: 80
Study 27526332 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 14
Study 27526332 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycling exercise
Number of subjects: 14
Study 27526332 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test and bicycling EIH
Number of subjects: 14
Study 26118144 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker-led group sessions based on the American Heart Association's Simple Seven curriculum (six sessions, one per month)
Number of subjects: 0
Study 26118144 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 0
Study 22951625 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (6 months vigorous aerobic exercise, AT group)
Number of subjects: 52
Study 22951625 — intervention group
Group type: COMPARATOR
Intervention: Non-aerobic group (6 months of no aerobic exercise, NA group)
Number of subjects: 52
Study 22043310 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient administered measures (Shared Decision Making Questionnaire, Control Preference Scale & Decisional Conflict Scale)
Number of subjects: 79
Study 22043310 — intervention group
Group type: COMPARATOR
Intervention: Observer ratings (OPTION)
Number of subjects: 79
Study 22043310 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient administered measures
Number of subjects: 79
Study 22043310 — intervention group
Group type: COMPARATOR
Intervention: Observer and patient judges
Number of subjects: 79
Study 18364522 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking routes
Number of subjects: 64
Study 18364522 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking-while-working
Number of subjects: 64
Study 18364522 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 17166388 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-produced Nedaplatin plus 5-fluorouracil (5-FU)
Number of subjects: 52
Study 17166388 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (DDP) plus 5-fluorouracil (5-FU)
Number of subjects: 52
Study 12716672 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 14 mg . kg(‐)(1) . d(‐)(1)
Number of subjects: 21
Study 12716672 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine intake of 15 mg . kg(‐)(1) . d(‐)(1)
Number of subjects: 21
Study 10737537 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous tumor cell vaccine (AV) plus bCG with sequential administration of IFN gamma and IFN alpha
Number of subjects: 14
Study 8737615 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol
Number of subjects: 25